Table 3.
Bazedoxifene | Raloxifene | Placebo | ||
---|---|---|---|---|
20 mg (n = 1886) |
40 mg (n = 1872) |
60 mg (n = 1849) |
(n = 1885) |
|
Total stroke | ||||
n | 12 | 14 | 12 | 14 |
Rate | 2.6 (1.34, 4.52) | 3.1 (1.70, 5.23) | 2.6 (1.36, 4.59) | 3.0 (1.65, 5.06) |
Hemorrhagic stroke | ||||
n | 1 | 1 | 1 | 2 |
Rate | 0.2 (0.01, 1.20) | 0.2 (0.01, 1.24) | 0.2 (0.01, 1.22) | 0.4 (0.05, 1.55) |
Ischemic stroke | ||||
n | 9 | 12 | 10 | 10 |
Rate | 1.9 (0.89, 3.69) | 2.7 (1.38, 4.66) | 2.2 (1.05, 4.02) | 2.2 (1.03, 3.96) |
Stroke (unspecified) | ||||
n | 2 | 1 | 1 | 2 |
Rate | 0.4 (0.05, 1.56) | 0.2 (0.01, 1.24) | 0.2 (0.01, 1.22) | 0.4 (0.05, 1.55) |
TIA | ||||
n | 5 | 7 | 3 | 4 |
Rate | 1.1 (0.35, 2.52) | 1.6 (0.63, 3.21) | 0.7 (0.14, 1.92) | 0.9 (0.23, 2.20) |
Fatal stroke | ||||
n | 1 | 1 | 1 | 2 |
CI, confidence interval; TIA, transient ischemic attack.